Health Care/Hospital
US FDA Awards Fast Track Designation (FTD) to Paxalisib for Glioblastoma
SYDNEY, Aug. 20, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to Kazia's paxalisib (forme...
2020-08-20 08:35
8678
Jamjoom Pharmaceuticals Earns Acclaim from Frost & Sullivan for its Dominance in the KSA Pharma Market with its Expanded Portfolio and Geographic Presence
Jamjoom Pharmaceuticals is dedicated to being a center of excellence in healthcare and providing high-quality, safe, and effective products to meet the regional need JEDDAH, Saudi Arabia, Aug. 19, 2020 /PRNewswire/ -- Based on its recent analysis of the KSA emerging generic pharmaceuticals marke...
2020-08-19 16:00
2048
Global Entertainment Giant YOOZOO Aligns with Health Tech Company Plano to Tackle the Global Myopia Epidemic
SINGAPORE, Aug. 19, 2020 /PRNewswire/ -- Plano Pte Ltd (hereinafter, Plano), a Singapore-based health technology startup, and one of the world's leading providers of interactive entertainment, YOOZOO, have inked a Memorandum of Understanding to address the global burden of myopia inSingapore, the...
2020-08-19 12:00
4571
CStone Pharmaceuticals Reports Financial Results for the First Half of 2020
SUZHOU, China, Aug. 19, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology (IO) therapies and precision medicines, today reported recent business highlights and financial resu...
2020-08-19 09:33
4552
Aon urges the re/insurance industry to bring capital closer to clients' needs as the firm launches its Virtual Reinsurance Renewal Season
Virtual event launches with former Danish Prime Minister Helle Thorning-Schmidt interview LONDON, Aug. 18, 2020 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional services firm providing a broad range of risk, retirement and health solutions, today launches itsVirtual Reinsurance...
2020-08-18 23:37
20772
athenahealth Earns the Frost & Sullivan 2020 RCM Company of the Year Award
athenahealth acclaimed by Frost & Sullivan for being at the forefront of solving critical RCM challenges and powering providers with agile solutions during the Covid-19 pandemic SANTA CLARA, California, Aug. 18, 2020 /PRNewswire/ -- Based on its recent analysis ofthe United States revenue cycle ...
2020-08-18 21:00
2660
Mindray Sets A New Standard for Infusion Systems with the BeneFusion n Series
SHENZHEN, China, Aug. 18, 2020 /PRNewswire/ -- Mindray (SZSE: 300760), a leading provider of medical devices and solutions, has released its new generation infusion system,BeneFusion n Series. By rethinking safety, simplicity, interoperability and data synergy, the BeneFusion n Series sets a new...
2020-08-18 21:00
6997
PharmAbcine announces the execution of a Material Cooperative Research and Development Agreement (MCRADA) with the NIH to evaluate the efficacy of PMC-403 to treat SCLS
DAEJEON, South Korea, Aug. 18, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a Materials Cooperative Research and Development Agreement (MCRADA) with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), in whic...
2020-08-18 21:00
8652
Ascentage Pharma Releases 2020 Interim Results, Reporting the Company's First New Drug Application and Advances in Global Strategic Collaborations
SUZHOU, China and ROCKVILLE, Md., Aug. 18, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced its interim results for the ...
2020-08-18 20:24
3786
Global Cord Blood Corporation to Report First Quarter Fiscal 2021 Financial Results
HONG KONG, Aug. 18, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release financial results fo...
2020-08-18 19:00
11493
Global Cord Blood Corporation to Report First Quarter Fiscal 2021 Financial Results
HONG KONG, Aug. 18, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release financial results fo...
2020-08-18 19:00
3894
Innovent and Lilly Announce Expansion of TYVYT® (Sintilimab Injection) Licensing Agreement
SUZHOU, China and INDIANAPOLIS, Aug. 18, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...
2020-08-18 18:30
6430
Koichiro Matsumoto Appointed President/CEO of Bushu Pharmaceuticals Ltd.
KAWAGOE, Japan, Aug. 18, 2020 /PRNewswire/ -- In response to requests for a professional contract development and manufacturing organization (CDMO) partner inAsia that can better meet the needs and challenges of the global market, Bushu Pharmaceuticals Ltd. (hereinafter "Bushu Pharma") appointed ...
2020-08-18 14:00
1758
Work Health Safety Expert warns Australian companies to be Vigilant.
NEWCASTLE, Australia, Aug. 18, 2020 /PRNewswire/ -- James Prout, CEO of Zokal Safety Australia, issued the following statement: "Australian business owners and directors should evaluate their safety systems and procedures as a matter of urgency," said work health safety specialist James Prout. "...
2020-08-18 07:17
2443
China Biologic Reports Financial Results for the Second Quarter of 2020
BEIJING, Aug. 17, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced its unaudited financial results for the second quarter of 2020. Second Quart...
2020-08-18 04:30
9905
WuXi Biologics Records Excellent Interim Results
Revenue Up 21.0% Y-o-Y to RMB1,944.1 Million Net Profit Up 62.6% to RMB730.7 Million Profit Attributable to Owners of the Company Up 63.6% Y-o-Y to RMB736.1 Million Adjusted Net Profit Up 40.7% Y-o-Y to RMB734.0 Million Diluted EPS Up 55.9% Y-o-Y to RMB0.53 Adjusted Diluted EPS Up 38.5% Y-o-Y to RMB...
2020-08-18 00:51
3253
Start of bridging pharmacokinetic and safety clinical trial of a novel solid pharmaceutical composition of AMPK activator O304
STOCKHOLM, Aug. 17, 2020 /PRNewswire/ -- In previous Phase I and Phase IIa clinical trials in healthy subjects and in type 2 diabetics, the small molecule AMPK activator compound O304 was administered as a suspension and with limited oral bioavailability. A novel formulation of O304 has now been ...
2020-08-17 22:13
2498
Sirtex Medical announces partnership with Magle Chemoswed
Collaboration grants Sirtex global use of innovative technology to develop novel imaging agent for interventional oncology WOBURN, Massachusetts, Aug. 17, 2020 /PRNewswire/ -- Sirtex Medical US Holdings, Inc. ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced a coll...
2020-08-17 20:00
2362
I-Mab Announces First Patient Dosed in Phase 1b Study of Plonmarlimab in Rheumatoid Arthritis in China
SHANGHAI and GAITHERSBERG, Md., Aug. 17, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the first patient has been dosed with plonmarlimab ...
2020-08-17 20:00
3576
CARsgen Announces the Publication of a Novel CAR-T Technology that Improves the Efficacy of CAR-T cells Against Solid Tumors without Requiring Preconditioned Lymphodepletion
SHANGHAI, Aug. 17, 2020 /PRNewswire/ -- CARsgen Therapeutics, a leader in developing novel CAR-T cell therapies against solid tumors, today announced its publication of the 7×21 CAR-T technology in CLINICAL CANCER RESEARCH. The article is titled "Coexpression of IL-7 and CCL21 increases efficacy ...
2020-08-17 18:00
4044
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
9173
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7712